Literature DB >> 21454391

Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study.

Mario R Korte1, Denise E Sampimon, Hester F Lingsma, Marien W Fieren, Caspar W N Looman, Robert Zietse, Willem Weimar, Michiel G H Betjes.   

Abstract

OBJECTIVE: Encapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal dialysis (PD) with a multifactorial pathophysiology and possible increasing incidence. The aim of the present study was to evaluate the independent associations of PD duration, age, dialysis fluids, and kidney transplantation with EPS.
METHODS: A multicenter case-control study was performed in the Netherlands from 1 January 1996 until 1 July 2007. The population comprised 63 patients with EPS and 126 control patients. Control patients were selected from the national registry and were matched for date of PD start. Associations were analyzed using a log linear regression model. Primary outcome was appearance of EPS.
RESULTS: Compared with control patients, patients with EPS were younger at the start of PD (34.7 ± 15.4 years vs. 51.5 ± 14.7 years, p < 0.0001). The cumulative period on PD was longer in EPS patients than in control patients (78.7 ± 37.8 months vs. 32.8 ± 24 months, p < 0.0001), and the cumulative period on icodextrin was also longer in EPS patients (32.7 ± 23.3 months vs. 18.1 ± 15.7 months, p = 0.006). Compared with control patients, more EPS patients underwent kidney transplantation (47 vs. 59, p < 0.0001). With regard to the period after transplantation, the yearly probability of EPS increased in the year after transplantation to 7.5% from 1.75%. In multivariate regression analysis, cumulative PD duration, age at PD start, transplantation, time from last transplantation to EPS, calendar time, time on icodextrin, and ultrafiltration failure were independently associated with EPS. Transfer from PD to hemodialysis for reasons other than suspected EPS could not be identified as a risk factor for EPS.
CONCLUSIONS: Duration of PD, age at PD start, kidney transplantation, time since last transplantation, ultrafiltration failure, and time on icodextrin were associated with a higher risk of EPS.

Entities:  

Mesh:

Year:  2011        PMID: 21454391     DOI: 10.3747/pdi.2010.00167

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  34 in total

1.  The peritoneal equilibration test should be included in routine monitoring of peritoneal dialysis patients.

Authors:  V Liakopoulos; O Nikitidou; M Divani; K Leivaditis; G Antoniadi; N V Dombros
Journal:  Perit Dial Int       Date:  2012 Mar-Apr       Impact factor: 1.756

2.  Towards standardized reporting in studies of encapsulating peritoneal sclerosis.

Authors:  Mark Lambie; Niko Braun; Simon J Davies
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

Review 3.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

4.  The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.

Authors:  Vincenzo La Milia; Selena Longhi; Elisabetta Sironi; Giuseppe Pontoriero
Journal:  J Nephrol       Date:  2016-12-24       Impact factor: 3.902

5.  Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis.

Authors:  Johann Morelle; Amadou Sow; Nicolas Hautem; Caroline Bouzin; Ralph Crott; Olivier Devuyst; Eric Goffin
Journal:  J Am Soc Nephrol       Date:  2015-01-30       Impact factor: 10.121

6.  Fibrosing pericarditis in a patient with encapsulating peritoneal sclerosis.

Authors:  L Tonneijck; S Florquin; M R Korte; N H Schut
Journal:  Perit Dial Int       Date:  2012 Nov-Dec       Impact factor: 1.756

Review 7.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

Review 8.  Can Free Water Transport Be Used as a Clinical Parameter for Peritoneal Fibrosis in Long-Term PD Patients?

Authors:  Raymond T Krediet; Deirisa Lopes Barreto; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

9.  Can EPS development be avoided with early interventions? The potential role of tamoxifen--a single-center study.

Authors:  Erika De Sousa-Amorim; Gloria Del Peso; M Auxiliadora Bajo; Laura Alvarez; Marta Ossorio; Fernando Gil; Teresa Bellon; Rafael Selgas
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Anthropometrics Identify Wasting in Patients Undergoing Surgery for Encapsulating Peritoneal Sclerosis.

Authors:  Rosalind Campbell; Titus Augustine; Helen Hurst; Ravi Pararajasingam; David van Dellen; Sheilagh Armstrong; Carol Bartley; Linda Birtles; Angela Summers
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.